More Features Archive listing feature articles

Why pharma must trust the science of behaviour

With behaviour being the best weapon we currently have to combat coronavirus, Chris Ross explores why the application of behavioural science will be key to better health far

Multichannel engagement and the need for greater understanding of European markets

By Laurence Olding and Georgina James

Keep your audiences close

How getting up close and personal with target audiences can fuel creativity

Launch leaders’ blog part 1

To delay or not to delay the launch – ‘that is the question’ nowadays

Q&A: Kate Callan

Are virtual congresses the new ‘jetpacks’?

By Nick Burgoyne

Go with the flow – a new concept for medical congresses?

By Christian Guhlke

Things are going to be different

By John Procter

Encouraging patient participation in real-world studies

By Bill Row, Bruce Capobianco and Maggie Adamski

Strategic planning: why do good strategies sometimes fail?

By Berit Sund and Heather Grant

Temporal engagement events: harnessing the unique possibilities of digital

By Harry Sharman

Facing up to virtual reality

As COVID-19 continues to have a cataclysmic impact on face-to-face events, 70% of event planners have moved some of their face-to-face meetings to virtual platforms and many believe that we’ll

Behaviour change during the coronavirus pandemic

By Lorraine Walters

Could coronavirus re-shape learning and development in pharma?

By Yvonne Ash

How healthcare comms needs to adapt

By Harry Yeates and Marc Astick

Integrated comms in the healthcare industry

By Alison Washer

Great minds don’t think alike

By Julia Crawford and Tom Wordley